Cytek Biosciences, Inc. (CTKB) reported revenue at $57.5 million

Cytek Biosciences, Inc. (NASDAQ: CTKB) reported revenue for the quarter came in at $57.5 million versus the consensus estimate of $61.49 million.

For earnings history and earnings-related data on Cytek Biosciences, Inc. (CTKB) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Morgan Stanley on Exelixis (EXEL): today's update 'mixed-to-negative at the margin'
• Taysha Gene Therapies (TSHA) PT Raised to $10 at BofA Securities